 | This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
|
 | |
 Julphar headquarters | |
| Company type | Public shareholding company |
|---|---|
| ADX: JULPHAR | |
| Industry | Pharmaceuticals |
| Founded | 1980 |
| Headquarters | Ras Al Khaimah, UAE |
Area served | Worldwide |
Key people | Sheikh Saqer Humaid Al Qasimi (Chairman) Jerome Carle (CEO)[1] |
| Revenue |  AED 1.43 billion (2014)[2] |
| AED 238.5 million (2014) | |
| AED 234.7 million (2014) | |
Number of employees | 5,000[3] |
| Website | www.julphar.net |
Julphar is an Emirati pharmaceutical manufacturer in the Middle East.[4] Headquartered in Ras Al Khaimah, United Arab Emirates, the company employs more than 5,000 people and distributes its pharmaceutical products internationally. The company has three divisions — General Medicines, Julphar Diabetes Solutions and Julphar Life. In 2018, the company was ranked as the number one pharmaceutical manufacturer in the UAE.[5]
- ^ "Julphar holds Annual General Meeting".
- ^ Fact Sheet (Report). Julphar. 2015. Archived from the original on 2016-03-16. Retrieved 2015-04-20.
- ^ "Julphar Gulf Pharmaceutical Industries - What We Do". Julphar.net.
- ^ "UAE-produced insulin now available in 17 countries". Gulf Business. 12 July 2017.
- ^ "Julphar named top pharma company in UAE". tradearabia.com.